Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Abstract Oncolytic adenoviruses (OAds), most of which are based on species C human adenovirus serotype 5 (Ad5) (OAd5), have recently received much attention as potential anticancer agents. High seroprevalence of anti-Ad5 neutralizing antibodies is a major hurdle for Ad5-based gene therapy. However,...
Main Authors: | Ryosuke Ono, Fumitaka Nishimae, Takuro Wakida, Fuminori Sakurai, Hiroyuki Mizuguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-26030-3 |
Similar Items
-
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
by: Martí Farrera-Sal, et al.
Published: (2020-04-01) -
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness
by: Martí Farrera-Sal, et al.
Published: (2020-07-01) -
Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment
by: Aleksander Gryciuk, et al.
Published: (2023-03-01) -
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01) -
Oncolytic Adenovirus in Cancer Immunotherapy
by: Malin Peter, et al.
Published: (2020-11-01)